210 related articles for article (PubMed ID: 10261791)
1. Controlling moxalactam and cefotaxime use with a target drug program.
Abramowitz PW; Ludwig DJ; Mansur JM; Nold EG
Hosp Pharm; 1983 Aug; 18(8):416-20. PubMed ID: 10261791
[TBL] [Abstract][Full Text] [Related]
2. Use of clinical pharmacists to reduce cefamandole, cefoxitin, and ticarcillin costs.
Abramowitz PW; Nold EG; Hatfield SM
Am J Hosp Pharm; 1982 Jul; 39(7):1176-80. PubMed ID: 7114059
[TBL] [Abstract][Full Text] [Related]
3. Contribution of clinical pharmacists to cefazolin utilization.
Witte KW; Hatoum HT; Hoon TJ
Hosp Formul; 1987 Aug; 22(8):737-41. PubMed ID: 10283405
[TBL] [Abstract][Full Text] [Related]
4. Cost containment through restriction of cephalosporins.
Britton HL; Schwinghammer TL; Romano MJ
Am J Hosp Pharm; 1981 Dec; 38(12):1897-900. PubMed ID: 7325168
[TBL] [Abstract][Full Text] [Related]
5. Cost savings achieved through cephalosporin use review and restriction.
Dzierba SH; Reilly RT; Caselnova DA
Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
[TBL] [Abstract][Full Text] [Related]
6. Antibiotic surveillance: the results of a clinical pharmacy intervention program.
Capers CC; Bess DT; Branam AC; Falbe WJ; Mrochek SA; Haymond JD; Stahl AA
Hosp Pharm; 1993 Mar; 28(3):206-10, 212. PubMed ID: 10124947
[TBL] [Abstract][Full Text] [Related]
7. Monitoring antibiotic prescriptions can reduce use and cost of drugs.
Douglas AS
Mod Healthc; 1984 Oct; 14(13):106-7. PubMed ID: 10268397
[No Abstract] [Full Text] [Related]
8. Savings achieved through cephalosporin surveillance.
Katz E; Schlamowitz S
Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
[TBL] [Abstract][Full Text] [Related]
9. Methods of controlling cephalosporin use in Canadian hospitals.
Godin JP; Sketris IS; Merrett RA; Marrie TJ
Can J Hosp Pharm; 1988 Apr; 41(2):73-4, 83-4, 96. PubMed ID: 10287052
[TBL] [Abstract][Full Text] [Related]
10. Pharmacy-laboratory interactions: a unique method to control antibiotic costs.
Goff D; Thornton J
Hosp Pharm; 1989 Jan; 24(1):26-9, 32. PubMed ID: 10291600
[TBL] [Abstract][Full Text] [Related]
11. Financial impact of formulary revision of second-generation cephalosporins.
Andrews JD; Hafting S
Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
[TBL] [Abstract][Full Text] [Related]
12. DUE (drug usage evaluation) of ticarcillin and clavulanate potassium: determining appropriate and cost-effective therapeutic options.
Lomaestro BM; Lesar TS
Hosp Formul; 1988 Nov; 23(11):909. PubMed ID: 10312767
[TBL] [Abstract][Full Text] [Related]
13. A strategy to reduce drug expenditures with a drug utilization review program.
Hoffmann RP
Hosp Pharm; 1984 Jan; 19(1):7-8, 11-2. PubMed ID: 10264746
[TBL] [Abstract][Full Text] [Related]
14. Controlling cephalosporin and aminoglycoside costs through pharmacy and therapeutics committee restrictions.
Hayman JN; Sbravati EC
Am J Hosp Pharm; 1985 Jun; 42(6):1343-7. PubMed ID: 4014250
[TBL] [Abstract][Full Text] [Related]
15. Appropriate but not cost effective ceftazidime use in a university hospital.
Colburn PA; Carver PA; Montgomery PA; Alaniz C; Chaffee BW; Amesbury BK
Hosp Pharm; 1989 Nov; 24(11):911-6, 928. PubMed ID: 10313376
[TBL] [Abstract][Full Text] [Related]
16. Use of staff pharmacists to reduce the inappropriate use of parenteral histamine-2 antagonist therapy.
Caldwell RD; Davis SK
Hosp Pharm; 1987 Dec; 22(12):1205-9. PubMed ID: 10285375
[TBL] [Abstract][Full Text] [Related]
17. Effect of antibiotic order form guiding rational use of expensive drugs on cost containment.
Sirinavin S; Suvanakoot P; Sathapatayavongs B; Malatham K
Southeast Asian J Trop Med Public Health; 1998 Sep; 29(3):636-42. PubMed ID: 10437971
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of an antibiotic cost containment measure.
Jung B; Andrews JD
Can J Hosp Pharm; 1990 Jun; 43(3):116-22. PubMed ID: 10105649
[TBL] [Abstract][Full Text] [Related]
19. Possible savings with appropriate antibiotic prophylaxis.
Hodgson T; Lannigan R; Mills D
Can J Hosp Pharm; 1984; 37(3):95-7. PubMed ID: 10268247
[TBL] [Abstract][Full Text] [Related]
20. Pharmacy initiatives to reduce clindamycin use.
Greene SA; Record KE; Rapp RP; Amerson AB; Bell RM; Piecoro JJ
Am J Hosp Pharm; 1986 May; 43(5):1210-3. PubMed ID: 3717177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
